Multimodal Sexual Dysfunction Intervention In HCT

NAActive, not recruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

January 1, 2023

Study Completion Date

December 31, 2024

Conditions
Hematopoietic Stem Cell TransplantationHematologic DiseasesSexual Dysfunction
Interventions
BEHAVIORAL

Enhanced Standard Care

"* Baseline data collection, registration and randomization~* Inform primary transplant clinician of sexual dysfunction causing distress~* Receive American Cancer Society sexual educational material"

BEHAVIORAL

Multimodal Intervention to Address Sexual Dysfunction

"Baseline data collection, registration and randomization~\- 3 Monthly visits with trained study nurse practitioners~* Referral to specialist if~* Psychological etiology~* Sexual Trauma~* Relationship Discord~* Concern for Malignancy or anatomic scarring requiring surgery"

Trial Locations (1)

02115

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

collaborator

The Leukemia and Lymphoma Society

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03803696 - Multimodal Sexual Dysfunction Intervention In HCT | Biotech Hunter | Biotech Hunter